US Stock MarketDetailed Quotes

CLSD Clearside Biomedical

Watchlist

1.090
+0.030+2.83%

Close Aug 9 16:00 ET

81.46MMarket Cap-1981P/E (TTM)

Clearside Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

5,650.00%230K

519.89%8.23M

1,822.73%6.35M

222.93%859K

165.10%1.02M

-98.85%4K

-95.51%1.33M

-98.72%330K

-91.35%266K

-50.77%384K

Operating revenue

5,650.00%230K

519.89%8.23M

1,822.73%6.35M

222.93%859K

165.10%1.02M

-98.85%4K

-95.51%1.33M

-98.72%330K

-91.35%266K

-50.77%384K

Cost of revenue

74.02%355K

142K

213K

204K

Gross profit

600.89%7.87M

4,935.71%6.35M

169.55%717K

109.64%805K

-96.20%1.12M

126K

266K

384K

Operating expense

10.91%8.44M

4.19%32.72M

12.98%9.26M

11.17%7.77M

-1.78%8.08M

-4.80%7.61M

3.97%31.4M

17.42%8.2M

-12.22%6.99M

19.56%8.22M

Selling and administrative expenses

-10.58%2.82M

0.84%11.87M

-7.01%2.95M

12.07%2.64M

12.04%3.13M

-8.65%3.16M

0.90%11.77M

0.92%3.17M

-16.44%2.35M

-0.89%2.79M

-General and administrative expense

-10.58%2.82M

0.84%11.87M

-7.01%2.95M

12.07%2.64M

12.04%3.13M

-8.65%3.16M

0.90%11.77M

0.92%3.17M

-16.44%2.35M

-0.89%2.79M

Research and development costs

26.15%5.62M

6.19%20.85M

25.58%6.31M

10.72%5.13M

-8.88%4.95M

-1.87%4.45M

5.90%19.63M

30.91%5.03M

-9.91%4.64M

33.74%5.43M

Operating profit

-7.94%-8.21M

17.94%-24.84M

63.88%-2.92M

-4.91%-7.05M

7.23%-7.27M

0.54%-7.61M

-4,728.87%-30.28M

-143.14%-8.07M

-37.53%-6.72M

-28.56%-7.84M

Net non-operating interest income expense

-22.69%-2.06M

-180.32%-9.36M

-11.51%-2.28M

-102.16%-2.62M

-2.29M

-1.68M

-3.34M

-2.04M

-1.3M

Non-operating interest income

-29.27%348K

----

--492K

----

Non-operating interest expense

10.89%2.4M

180.32%9.36M

11.51%2.28M

102.16%2.62M

--2.29M

--2.17M

--3.34M

--2.04M

--1.3M

--0

Other net income (expense)

-1.5M

156.95%1.72M

-19.82%360K

110.82%409K

1,808.33%458K

-33.30%669K

22,350.00%449K

9,600.00%194K

2,300.00%24K

Other non- operating income (expenses)

---1.5M

156.95%1.72M

-19.82%360K

110.82%409K

1,808.33%458K

----

-33.30%669K

22,350.00%449K

9,600.00%194K

2,300.00%24K

Income before tax

-26.76%-11.76M

1.40%-32.49M

49.99%-4.83M

-18.40%-9.27M

-16.55%-9.11M

-21.40%-9.28M

-8,862.50%-32.95M

-151.65%-9.66M

-60.16%-7.83M

-28.19%-7.81M

Income tax

Net income

-26.76%-11.76M

1.40%-32.49M

49.99%-4.83M

-18.40%-9.27M

-16.55%-9.11M

-21.40%-9.28M

-8,862.50%-32.95M

-151.65%-9.66M

-60.16%-7.83M

-28.19%-7.81M

Net income continuous Operations

-26.76%-11.76M

1.40%-32.49M

49.99%-4.83M

-18.40%-9.27M

-16.55%-9.11M

-21.40%-9.28M

-8,862.50%-32.95M

-151.65%-9.66M

-60.16%-7.83M

-28.19%-7.81M

Minority interest income

Net income attributable to the parent company

-26.76%-11.76M

1.40%-32.49M

49.99%-4.83M

-18.40%-9.27M

-16.55%-9.11M

-21.40%-9.28M

-8,862.50%-32.95M

-151.65%-9.66M

-60.16%-7.83M

-28.19%-7.81M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-26.76%-11.76M

1.40%-32.49M

49.99%-4.83M

-18.40%-9.27M

-16.55%-9.11M

-21.40%-9.28M

-8,862.50%-32.95M

-151.65%-9.66M

-60.16%-7.83M

-28.19%-7.81M

Basic earnings per share

-13.33%-0.17

3.64%-0.53

50.00%-0.08

-15.38%-0.15

-5,600.00%-0.55

-151.61%-0.16

-62.50%-0.13

-18.18%-0.13

Diluted earnings per share

-13.33%-0.17

3.64%-0.53

50.00%-0.08

-15.38%-0.15

-5,600.00%-0.55

-151.61%-0.16

-62.50%-0.13

-18.18%-0.13

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	5,650.00%230K	519.89%8.23M	1,822.73%6.35M	222.93%859K	165.10%1.02M	-98.85%4K	-95.51%1.33M	-98.72%330K	-91.35%266K	-50.77%384K
Operating revenue	5,650.00%230K	519.89%8.23M	1,822.73%6.35M	222.93%859K	165.10%1.02M	-98.85%4K	-95.51%1.33M	-98.72%330K	-91.35%266K	-50.77%384K
Cost of revenue		74.02%355K	0	142K	213K		204K	204K	0	0
Gross profit		600.89%7.87M	4,935.71%6.35M	169.55%717K	109.64%805K		-96.20%1.12M	126K	266K	384K
Operating expense	10.91%8.44M	4.19%32.72M	12.98%9.26M	11.17%7.77M	-1.78%8.08M	-4.80%7.61M	3.97%31.4M	17.42%8.2M	-12.22%6.99M	19.56%8.22M
Selling and administrative expenses	-10.58%2.82M	0.84%11.87M	-7.01%2.95M	12.07%2.64M	12.04%3.13M	-8.65%3.16M	0.90%11.77M	0.92%3.17M	-16.44%2.35M	-0.89%2.79M
-General and administrative expense	-10.58%2.82M	0.84%11.87M	-7.01%2.95M	12.07%2.64M	12.04%3.13M	-8.65%3.16M	0.90%11.77M	0.92%3.17M	-16.44%2.35M	-0.89%2.79M
Research and development costs	26.15%5.62M	6.19%20.85M	25.58%6.31M	10.72%5.13M	-8.88%4.95M	-1.87%4.45M	5.90%19.63M	30.91%5.03M	-9.91%4.64M	33.74%5.43M
Operating profit	-7.94%-8.21M	17.94%-24.84M	63.88%-2.92M	-4.91%-7.05M	7.23%-7.27M	0.54%-7.61M	-4,728.87%-30.28M	-143.14%-8.07M	-37.53%-6.72M	-28.56%-7.84M
Net non-operating interest income expense	-22.69%-2.06M	-180.32%-9.36M	-11.51%-2.28M	-102.16%-2.62M	-2.29M	-1.68M	-3.34M	-2.04M	-1.3M	0
Non-operating interest income	-29.27%348K	----	----	----	----	--492K	----	----	----	----
Non-operating interest expense	10.89%2.4M	180.32%9.36M	11.51%2.28M	102.16%2.62M	--2.29M	--2.17M	--3.34M	--2.04M	--1.3M	--0
Other net income (expense)	-1.5M	156.95%1.72M	-19.82%360K	110.82%409K	1,808.33%458K		-33.30%669K	22,350.00%449K	9,600.00%194K	2,300.00%24K
Other non- operating income (expenses)	---1.5M	156.95%1.72M	-19.82%360K	110.82%409K	1,808.33%458K	----	-33.30%669K	22,350.00%449K	9,600.00%194K	2,300.00%24K
Income before tax	-26.76%-11.76M	1.40%-32.49M	49.99%-4.83M	-18.40%-9.27M	-16.55%-9.11M	-21.40%-9.28M	-8,862.50%-32.95M	-151.65%-9.66M	-60.16%-7.83M	-28.19%-7.81M
Income tax
Net income	-26.76%-11.76M	1.40%-32.49M	49.99%-4.83M	-18.40%-9.27M	-16.55%-9.11M	-21.40%-9.28M	-8,862.50%-32.95M	-151.65%-9.66M	-60.16%-7.83M	-28.19%-7.81M
Net income continuous Operations	-26.76%-11.76M	1.40%-32.49M	49.99%-4.83M	-18.40%-9.27M	-16.55%-9.11M	-21.40%-9.28M	-8,862.50%-32.95M	-151.65%-9.66M	-60.16%-7.83M	-28.19%-7.81M
Minority interest income
Net income attributable to the parent company	-26.76%-11.76M	1.40%-32.49M	49.99%-4.83M	-18.40%-9.27M	-16.55%-9.11M	-21.40%-9.28M	-8,862.50%-32.95M	-151.65%-9.66M	-60.16%-7.83M	-28.19%-7.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-26.76%-11.76M	1.40%-32.49M	49.99%-4.83M	-18.40%-9.27M	-16.55%-9.11M	-21.40%-9.28M	-8,862.50%-32.95M	-151.65%-9.66M	-60.16%-7.83M	-28.19%-7.81M
Basic earnings per share	-13.33%-0.17	3.64%-0.53	50.00%-0.08	-15.38%-0.15	-15.38%-0.15	-15.38%-0.15	-5,600.00%-0.55	-151.61%-0.16	-62.50%-0.13	-18.18%-0.13
Diluted earnings per share	-13.33%-0.17	3.64%-0.53	50.00%-0.08	-15.38%-0.15	-15.38%-0.15	-15.38%-0.15	-5,600.00%-0.55	-151.61%-0.16	-62.50%-0.13	-18.18%-0.13
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall